Company Profile RTW Biotech Opportunities Ltd. Guernsey IndustryClosed-End Funds SectorFinancial Services Fiscal Year-end12/2023 Revenue$7.78M Net Income-$39.44M 2022 Sales GrowthN/A EmployeesN/A ...

Specifically, PGGL Family Trust LLC now holds 14.8781%, Wong Gift Trust 2019 holds 0.0878%, and RTW Fund Group GP LLC holds 0.0341% of the voting rights.

Biotech InnoCare, Keymed sell ex-China rights for bispecific to RTW-built biotech in $520M deal By James Waldron Jan 21, 2025 4:32am bispecific antibodies Licensing deals lymphoma RTW Investments ...

The new logo retains the blue colour, symbolising trust and stability, while incorporating a vibrant green accent that embodies growth. The modern, energetic font reflects the fund house’s ...

RTW Investments is being investigated by the Securities and Exchange Commission (SEC) for its alleged involvement in an empty voting scheme in relation to a proxy battle between Masimo Corp. and ...

(Bloomberg) -- RTW Investments, a $6.5 billion hedge fund specializing in the life sciences, is being investigated by the Securities and Exchange Commission over the firm’s involvement in a proxy ...

RTW Investments, a $6.5 billion hedge fund specializing in the life sciences, is being investigated by the Securities and Exchange Commission over the firm’s involvement in a proxy fight at ...

US clinical-stage biotech Obsidian Therapeutics has closed a significantly oversubscribed $160.5 million Series C financing with a top-tier syndicate of life science investors led by new investor, ...

Additional new investors participating in the financing include Foresite Capital, Janus Henderson Investors, Novo Holdings A/S, Paradigm BioCapital, RTW Investments, funds and accounts advised by ...

There’s a plethora of immunology drugs on the market. But Mirador notes that for many patients, these drugs don’t work well enough, if at all. The startup aims to discover better drugs by ...

Mirador Therapeutics, a precision medicine startup, launched with $400 million in financing Thursday as it looks to advance multiple therapeutic programs targeting immune-mediated inflammatory and ...